"While researchers investigate recovered patient antibody treatments for COVID-19, intravenous immunoglobulin (IVIg) is a similar type of treatment that is already available and could be used for COVID-19. IVIg is generated from the pooled immunoglobulin G of approximately one thousand blood donors. As the frequency of patients that have recovered from COVID-19 increases, the likelihood of having a recovered donor patient increases. These donors could be recovered or asymptomatic COVID-19 patients. Recovered patients only have to wait 28 days before they are cleared for donating. IVIg differs from recovered patient antibodies in that there is no guarantee that the pooling contains COVID-19-specific antibodies.While a vaccine and an approved recovered patient antibody treatment are still in the works, IVIg could help save patient’s lives in the meantime.”

Johanna Swanson, Product Manager, GlobalData, US